REFERENCES
- Ravikumar A, Arun P. Devi KY, Augustinc J, Kurup PA. Isoprenoid pathway and free radical generation and damage in neuropsychiatry disorders. Indian J Exp Biol. 2000; 38: 438–446.
- Yao JK, Reddy RD, Van Kammen DP. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic interventions. CNS Drugs. 2001; 15: 287–310.
- Herken H, Uz E, Ozurt H, Sogut S, Virit O, Akyol O. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol Psychiatry. 2001; 6: 66–73.
- Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord. 2001; 88: 69–71.
- Cohen G. Oxyradical toxicity in catecholamine neurons. Neurotoxicology. 1984; 5: 77–82.
- Fridovich I. Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol Toxicol. 1983; 23: 239–257.
- Pandey GN, Sharma RJ, Janicak PG, Davis JM. Monoamine oxidase and cortisol response in depression and schizophrenia. Psychiatr Res. 1992; 44: 1–8.
- Seregi A, Schaefer A, Komlos M. Protective role of brain ascorbic acid content against lipid peroxidation. Experientia. 1978; 34: 1056–1057.
- Stocks J, Gutteridge JMC, Sharp RJ, Dormandy TL. Assay usingbrain homogenate for measuring the antioxidant activity of biological fluids. Clin Sci Mol Med. 1974; 47: 215–222.
- Baldessarini RJ. Drugs and the treatment of psychiatric disorders: depression and mania. In: Molinoff PB, Ruddon RW. (eds) Goodman and Gilman 's - The Pharmacological Basis of Therapeutics. 10th edn. New York: McGraw-Hill, 2000; 447-480.
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr. 1960; 23: 56–62.
- Kei S. Lipid peroxides in cerebrovascular disorders determined by new colorimetric method. Clin Chim Acta. 1978; 90: 37–43.
- Nischal HK, Sharma MP, Goyal RK, Kanshi GG. Serum superoxide dismutase levels in diabetes mellitus with or without microangiopathic complications. J Assoc Physicians India. 1998; 46: 853–855.
- Aye K. A simple colorimetric method for ascorbic acid determin-ation in blood plasma. Clin Chim Acta. 1978; 86: 153–157.
- Macs M, Christophe A, Delange J, Neels H, Sharpe S, Meltzer HY. Lowered omega 3 polyunsaturated fatty acids in serum phospholipids and cholesterol esters of depressed patients. Psychiatr Res. 1999; 85: 275–291.
- Hibbeln JR, Salem N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr. 1995; 62: 1–9.
- Shigennobu UMS, Yoshihito N, Rinzo S. Concentrations of superoxide dismutase and superoxide anion in blood of patients with respiratory infections and compromised immune systems. Clin Chem. 1987; 31: 2230–2233.
- Fridovich I. Superoxide radicals and superoxide dismutases. Annu Rev Biochem. 1995; 64: 97–112.
- Konat GW, Wiggins RC. Effect of reactive oxygen species on myelin membrane proteins. J Neurochem. 1985; 45: 1113–1118.
- Cadet JL, Kahler LA. Free radical mechanisms in schizophrenia and tardive dyskinesia. Neurosci Biobehav Rev. 1994; 18: 457–467.
- Liu J, Mori A. Monoamine metabolism provides an antioxidant defense in the brain against oxidant and free radical induced damage. Arch Biochem Biophys. 1993; 302: 118–127.
- Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Nemoto T, Shields P. Manganese superoxide dismutase, genetic polymorphism, dietary antioxidants and risk of breast cancer. Cancer Res. 1999; 59: 602–606.
- Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984; 219: 1–14.
- Sen CK. Oxygen toxicity and antioxidants: state of the art. Indian J Physiol Pharmacol. 1995; 39: 177–196.
- Macs M, DeVos N, Pioli R, Demedts P. Wauters A, Neels. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord. 2000; 58: 241–246.
- Sen CK, Hanninen O. Physiological antioxidants. In: Sen CK, Packer L, Hanninen O. (eds) Exercise and Oxygen Toxicity. Amsterdam: Elsevier, 1994; 89–126.
- Li XM, Chian FJ, Juorio AV, Bennett VL, Shrikhande S, Bowen RO. Antidepressants upregulate m-RNA levels of the neuroprotective enzyme, superoxide dismutase. J Psychiatr Neurosci. 2000; 25: 43–47.
- Bezchlibnyk K, Aleksic I, Kennedy SH. Citalopram - a review of pharmacological and clinical effects. J Psychiatr Neurosci. 2000; 25: 241–254.